Literature DB >> 2473046

Replication of HIV in human fetal retinal cultures and established pigment epithelial cell lines.

K Dutt1, D York, H J Kaplan, E Semple, G Verly, A Srinivasan.   

Abstract

The ability of the human immunodeficiency virus type 1 (HIV-1) to replicate in cells derived from ocular tissue was studied. Primary retinal cultures (containing both glial and neuronal cells) were found to support the replication of HIV upon transfection with molecularly cloned proviral DNA. In addition, established retinal pigment epithelial (RPE) cell lines also produced HIV particles upon transfection. HIV released by these cell lines was able to infect and induce characteristic cytopathic effects in T4+ cells. An indicator plasmid containing the HIV long terminal repeat sequences (LTR) linked to the chloramphenicol acetyltransferase gene showed barely detectable activity in RPE cells and was transactivated by the addition of the HIV "tat" gene. Based on these observations, direct infection of ocular tissue derived cells such as RPE, fetal retinal cells, retinoblastoma cells (Y 79, WER1), choroidal endothelial cells (Chor 55) (mix culture) and corneal fibroblasts (K61) by HIV was attempted. HIV replication in these cells was not detected by reverse transcriptase, antigen and transactivation function assays.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473046

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  2 in total

1.  Susceptibility of human retinal pigment epithelial cells to different viruses.

Authors:  H P Huemer; C Larcher; W Kirchebner; J Klingenschmid; W Göttinger; E U Irschick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

2.  Infection of Human Retinal Pigment Epithelium with Chlamydia trachomatis.

Authors:  Ernest Boiko; Dmitrii Maltsev; Alevtina Savicheva; Kira Shalepo; Tatyana Khusnutdinova; Alexei Pozniak; Igor Kvetnoi; Viktoria Polyakova; Alexei Suetov
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.